TIPS for patients with early HCC: A bridge to liver transplantation

Area of Science:

• Hepatology
• Interventional Radiology
• Oncology

Background:

• Cirrhosis frequently leads to portal hypertension (PHT) and hepatocellular carcinoma (HCC), complicating patient management.
• Hepatocellular carcinoma (HCC) is typically a contraindication for transjugular intrahepatic portosystemic shunt (TIPS) placement.
• Effective management of PHT is crucial for patients with advanced liver disease and HCC.

Observation:

• This study observed 8 patients diagnosed with HCC who underwent TIPS between 2010 and 2020.
• The study monitored liver function, tumor progression, and outcomes following TIPS placement in HCC patients.
• Patients receiving TIPS were evaluated for their suitability for subsequent liver transplantation.

Findings:

• Transjugular intrahepatic portosystemic shunt (TIPS) placement was not associated with worsening liver function in HCC patients.
• TIPS did not lead to increased tumor spread or metastasis in the observed cohort.
• All patients who received TIPS subsequently underwent liver transplantation, indicating successful bridging therapy.

Implications:

• TIPS can be a viable option for managing complications like variceal bleeding in HCC patients.
• TIPS may improve liver function, making patients eligible for liver transplantation when other treatments are precluded by PHT or ascites.
• Consideration of TIPS in HCC management, particularly as a bridge to transplantation, warrants further investigation.